Long post, sorry. Victoza (liraglutide): what actually has human evidence behind it, and what is extrapolation from animals?
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Titration is slow by design and rushing it is how people end up miserable.
What would change your mind about this?
Most of what is called evidence here is one person, one vial, one month.
How long before you can reasonably say something is or is not doing anything?
Where does the human data stop and the extrapolation begin? That is the whole thread.
Read methods.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial.
Name the active ingredient, not just the brand. It makes these threads searchable years later. Same for me with liraglutide, unfortunately.
Baseline first.
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Same here.
Is a baseline blood test really necessary before starting something like this?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.